An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

Michael Crump, Carol A. Sawka, Gerrit DeBoer, Roger B. Buchanan, James N. Ingle, John Forbes, J. William Meakin, Wendy Shelley, Kathleen I. Pritchard

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint Dive into the research topics of 'An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences